Literature DB >> 20685761

Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.

S Sotgiu1, G Mameli, C Serra, I R Zarbo, G Arru, A Dolei.   

Abstract

Retrovirus-like particles containing the multiple sclerosis-associated retrovirus RNA, significantly found in the cerebrospinal fluid of patients with multiple sclerosis, have been preliminarily associated with a short-term poor clinical and radiological prognosis of the disease. We asked whether these prognostic indications are still measurable after a long-term clinical evaluation (10 years). Our 10-year blind observational study confirms that the presence of multiple sclerosis-associated retrovirus in the cerebrospinal fluid of early multiple sclerosis patients is associated with a significantly greater rate of relapse-unrelated unremitting disability and secondary progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685761     DOI: 10.1177/1352458510376956

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  34 in total

Review 1.  Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.

Authors:  Bharath Wootla; Jens O Watzlawik; Nikolaos Stavropoulos; Nathan J Wittenberg; Harika Dasari; Murtada A Abdelrahim; John R Henley; Sang-Hyun Oh; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Opin Biol Ther       Date:  2016-03-10       Impact factor: 4.388

2.  pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis.

Authors:  David Kremer; Joel Gruchot; Vivien Weyers; Lisa Oldemeier; Peter Göttle; Luke Healy; Jeong Ho Jang; Yu Kang T Xu; Christina Volsko; Ranjan Dutta; Bruce D Trapp; Hervé Perron; Hans-Peter Hartung; Patrick Küry
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

Review 3.  Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections.

Authors:  Borros Arneth
Journal:  J Neurol       Date:  2018-02-08       Impact factor: 4.849

4.  Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.

Authors:  Xiaoning Tu; Shan Li; Lijuan Zhao; Ran Xiao; Xiuling Wang; Fan Zhu
Journal:  Virol Sin       Date:  2017-08-22       Impact factor: 4.327

5.  Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.

Authors:  Giuseppe Mameli; Luciana Poddighe; Alessandra Mei; Elena Uleri; Stefano Sotgiu; Caterina Serra; Roberto Manetti; Antonina Dolei
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

6.  Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.

Authors:  François Curtin; Hervé Perron; Raphael Faucard; Hervé Porchet; Alois B Lang
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

7.  Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.

Authors:  François Curtin; Hervé Perron; Arno Kromminga; Hervé Porchet; Alois B Lang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 8.  Human endogenous retroviruses and the nervous system.

Authors:  Renée N Douville; Avindra Nath
Journal:  Handb Clin Neurol       Date:  2014

9.  Activation of elements in HERV-W family by caffeine and aspirin.

Authors:  Chunlan Liu; Yatang Chen; Shan Li; Honglian Yu; Jie Zeng; Xiuling Wang; Fan Zhu
Journal:  Virus Genes       Date:  2013-06-28       Impact factor: 2.332

Review 10.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.